title: Conducting radiogenomic research--do not forget careful consideration of the clinical data.
abstract: The field of radiogenomics has evolved substantially over the last few years. Cooperative research groups have been established and high throughput genotyping has become increasingly feasible and affordable. Nevertheless, a number of clinical and dosimetric issues need to be carefully considered in order to fully exploit these new possibilities.
authors.affiliation: Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark. nicolaj@oncology.dk
authors.forename: Christian Nicolaj
authors.initials: CN
authors.lastname: Andreassen
authors.forename: Gillian C
authors.initials: GC
authors.lastname: Barnett
authors.forename: Johannes A
authors.initials: JA
authors.lastname: Langendijk
authors.forename: Jan
authors.initials: J
authors.lastname: Alsner
authors.forename: Dirk
authors.initials: D
authors.lastname: De Ruysscher
authors.forename: Mechtild
authors.initials: M
authors.lastname: Krause
authors.forename: Søren M
authors.initials: SM
authors.lastname: Bentzen
authors.forename: Joanne S
authors.initials: JS
authors.lastname: Haviland
authors.forename: Clare
authors.initials: C
authors.lastname: Griffin
authors.forename: Philip
authors.initials: P
authors.lastname: Poortmans
authors.forename: John R
authors.initials: JR
authors.lastname: Yarnold
mesh_terms: D035843:Biomedical Research; D019317:Evidence-Based Medicine; D023281:Genomics; D005838:Genotype; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000532:radiotherapy*; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide